35852-75-6 Usage
Uses
Used in Pharmaceutical Industry:
3-chloro-4-nitro-1H-Pyrazole is used as a chemical intermediate for the synthesis of various pharmaceuticals. Its unique structure allows it to be a key component in the development of new drugs, contributing to the advancement of medicinal chemistry.
Used in Agrochemical Industry:
In the agrochemical sector, 3-chloro-4-nitro-1H-Pyrazole serves as an intermediate in the production of agrochemicals. Its incorporation aids in the creation of effective pesticides and other agricultural products designed to protect crops and enhance yield.
Used in Dye and Pigment Production:
3-chloro-4-nitro-1H-Pyrazole is utilized as a building block in the manufacturing process of dyes and pigments. Its chemical properties make it suitable for creating a wide range of colors and hues used in various industries, including textiles, plastics, and printing.
Check Digit Verification of cas no
The CAS Registry Mumber 35852-75-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,5,8,5 and 2 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 35852-75:
(7*3)+(6*5)+(5*8)+(4*5)+(3*2)+(2*7)+(1*5)=136
136 % 10 = 6
So 35852-75-6 is a valid CAS Registry Number.
35852-75-6Relevant academic research and scientific papers
FUSED PYRIMIDINE COMPOUNDS, COMPOSITIONS AND MEDICINAL APPLICATIONS THEREOF
-
Paragraph 0244, (2021/04/02)
The present disclosure relates to a class of fused pyrimidine compounds of Formula I, their stereoisomers, tautomers, pharmaceutically acceptable salts, polymorphs, solvates, and hydrates thereof. The present disclosure also relates to a process of preparation of these fused pyrimidine compounds, and to pharmaceutical compositions containing them.
PYRROLOPYRIMIDINE COMPOUNDS, USE AS INHIBITORS OF THE KINASE LRRK2, AND METHODS FOR PREPARATION THEREOF
-
Paragraph 00433, (2017/07/06)
The present disclosure is concerned with certain pyrrolopyrimidine compounds that are capable of inhibiting certain protein kinases, and especially the leucine-rich repeat kinase 2 (LRRK2) protein. Compounds of the present disclosure can be used to treat
